Revolutionizing Instrument Free Diagnostics with Mass Producible Cartridges.
High Sensitivity. Affordable. Point-of-Care.
Our innovative photonic point-of-care (PoC) cartridges provide a groundbreaking solution for DNA testing, addressing critical needs in disease monitoring, especially in remote and disadvantaged communities. In these remote communities, a traditional bench top instrument is not feasable. This technology offers significant benefits in several key areas:
Rapid Results: Provides high-sensitivity results in minutes, allowing for timely medical interventions.
Accurate Detection: Capable of detecting trace amounts of pathogens, ensuring reliable diagnoses.
Accessibility: Portable and easy-to-use, these cartridges can be deployed in areas without specialized laboratory facilities.
Cost-Effective: Eliminates the need for expensive PCR machines and extensive lab setups, making testing affordable.
Multi-Target Capability: Multi-Target Capability: Can simultaneously test for multiple diseases, improving efficiency in resource-limited settings.
Immediate Decision-Making: Rapid testing within 15 minutes helps in swift isolation and treatment, crucial for controlling outbreaks.
On-Site Testing: Eliminates delays associated with sending samples to distant labs, crucial for preventing the spread of infections.
Multi-Target Testing: Single cartridge can test for various diseases in one go, offering comprehensive screening.
Test to mass screening: The first-generation cartridge can test up to 8 people simultaneously, making it ideal for high-throughput settings.
Label-Free Sensor: Accommodates a wide range of LAMP, immunoassay, and other recognition elements compatible with standard SPR sensors.
Our technology integrates advanced photonic sensors with molecular assays, providing a platform for high-sensitivity, low-cost diagnostic tests. Whether for personal use or high-throughput clinical settings, our devices are versatile and user-friendly.
Disease | Annual Cases (North America) | Estimated Annual Cost In USA |
---|---|---|
Salmonella | 1.35 million infections, 26,500 hospitalizations, 420 deaths | $3.7 billion |
E.coli | 265,000 infections, 3,600 hospitalizations, 30 deaths | $405 billion |
Listeria | 1,600 infections, 260 deaths | $2.6 billion |
Disease | Annual Cases (North America) | Estimated Annual Cost In USA |
---|---|---|
Chlamydia | 1.65 million reported cases in the USA | $3.7 billion |
Gonorrhea | 677,769 reported cases in the United States | $405 billion |
Syphilis | 176,713 reported case in the USA | $2.6 billion |
Herpes | CDC estimates 28 million people carrying the virus without knowing. | $2.4 billion |
Website Created By sohanthink